Modulating immune responses by targeting dendritic cells using dendritic cell specific markers.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/356269

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The ability to modulate immune responses would have major health benefits. Dendritic cells (DC) are key regulators of the immune system. Different types of DC possess different cell surface molecules and have differing regulatory functions. We have identified four novel DC surface molecules that can be used to target different types of DC. We aim to use antibodies against these molecules to either enhance the effectiveness of vaccines or to suppress autoimmune diseases.

Funded Activity Details

Start Date: 01-01-2005

End Date: 01-01-2005

Funding Scheme: NHMRC Development Grants

Funding Amount: $197,750.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Cell surface molecules | Dendritic cells | Modulating Immune Response | Tumour vaccines | Viral vaccines

Related Links